Dolutegravir (as sodium)/Lamivudine/Tenofovir Disoproxil Fumarate 50mg/300mg/300mg Tablets is contraindicated in patients with clinically significant hypersensitivity to tenofovir, lamivudine, dolutegravir or to any of the excipients contained in the formulation.
Co-administration with dofetilide (see Interactions).